SCHEMBL1573301

SCHEMBL1573301

COc1c(C)c(C(=O)c2ccc(N)c(C(=O)O)c2)n2cccc(OCCOCCOCCOCCOCCOCCOc3cccn4c(C(=O)c5ccc(N)c(C(=O)O)c5)c(C)c(OC)c34)c12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.38
▸ ALDH1A1 P00352 4/20 0.38
▸ PTK2B Q14289 1/20 0.38
▸ MAPT P10636 7/20 0.36
▸ MEN1 O00255 4/20 0.36
▸ LMNA P02545 4/20 0.36
▸ TDP1 Q9NUW8 2/20 0.36
▸ RECQL P46063 1/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.34
▸ ALOX15 P16050 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ CASP1 P29466 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ CBX7 O95931 1/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ TUBB4A P04350 1/20 0.33
▸ TUBB P07437 1/20 0.33
▸ TUBA3C P0DPH7 1/20 0.33
▸ TUBA1B P68363 1/20 0.33
▸ TUBA4A P68366 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4496071 1.00 KMT2A (0.38) KMT2AALDH1A1PTK2BMAPTMEN1
SCHEMBL1572736 0.96 KMT2A (0.35) KMT2AALDH1A1PTK2BMAPTMEN1
SCHEMBL1573188 0.93 ALDH1A1 (0.35) KMT2AALDH1A1PTK2BMAPTMEN1
SCHEMBL4516628 0.92 KDM4E (0.37) KMT2AALDH1A1MAPTMEN1LMNA
SCHEMBL13918695 0.92 KDM4E (0.37) KMT2AALDH1A1MAPTMEN1LMNA
SCHEMBL4500669 0.91 LMNA (0.34) KMT2AALDH1A1PTK2BMAPTMEN1
SCHEMBL4503731 0.90 MAPT (0.34) KMT2AALDH1A1PTK2BMAPTMEN1
SCHEMBL1572836 0.88 RXRA (0.41) KMT2AALDH1A1MAPTMEN1KDM4E
SCHEMBL13918704 0.88 KDM4E (0.34) KMT2AALDH1A1MAPTMEN1LMNA
SCHEMBL4504061 0.88 KDM4E (0.34) KMT2AALDH1A1MAPTMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9120819-B2 FGF-receptor agonist dimeric compounds SANOFI (FR) 2015-09-01 — — US claimed
EP-2018165-B1 FGF-PECEPTOR AGONIST DIMERIC COMPOUNDS SANOFI AVENTIS (FR) 2011-04-13 — — EP claimed
US-20090069368-A1 FGF-RECEPTOR AGONIST DIMERIC COMPOUNDS SANOFI-AVENTIS (FR) 2009-03-12 — — US claimed
US-9120819-B2 FGF-receptor agonist dimeric compounds SANOFI (FR) 2015-09-01 — — US disclosed
US-20090069368-A1 FGF-RECEPTOR AGONIST DIMERIC COMPOUNDS SANOFI-AVENTIS (FR) 2009-03-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069368-A1 FGF-RECEPTOR AGONIST DIMERIC COMPOUNDS FGF2, FGFR1, FGF1 KMT2A 3395/4885ALDH1A1 1044/4885PTK2B 352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback